Novel drug target for severe allergic reactions identifiedJanuary 30th, 2009 - 5:38 pm ICT by ANI
Washington, Jan 30 (ANI): An international team of researchers has identified a novel target that may lead to the development of new class of allergy drugs.
The researchers have come across a chemical called eotaxin that helps immune cells locate the site of infection and blocks basic “fighter” cells from transforming into “seeker” dendritic cells, resulting in a heightened allergic response.
“Our study reveals a new role for the chemokine eotaxin in controlling immune cell types at the site of allergic reaction,” said researcher Nigel Stevenson.
“These findings are crucial for our understanding of allergic responses and may be instrumental for the design of new allergy drugs,” he added.
During the study, the researchers used the immune cells grown in the lab and from healthy volunteers.
They mimicked what occurs during an allergic reaction by treating the cells with eotaxin, which was previously believed to only attract immune cells during an allergic reaction.
The researchers then tracked changes in immune cell type and found that eotaxin inhibits monocytes becoming dendritic cells (that find foreign invaders so other immune cells can neutralize them), resulting in more “fighter” cells being present during an allergic response.
“For some people, allergies are very serious often debilitating problem, forcing them to be extremely careful about what they breathe, touch, or eat,” said E. John Wherry, Deputy Editor of the Journal of Leukocyte Biology in which the study is published.
“The insights from this work on the unexpected role of eotaxin should provide novel therapeutic opportunities for intervention during diseases like asthma, food allergies and other situations where unchecked allergic responses cause problems,” he added. (ANI)
- New research solves riddle of allergic reactions - Feb 02, 2009
- Discovery could prevent deaths from severe flu outbreaks - Mar 01, 2012
- Cell component that triggers cat allergy identified - Mar 10, 2011
- Loneliness 'ups risk of inflammatory diseases' - Feb 09, 2011
- Breakthrough may pave way for new malaria drugs - Nov 27, 2011
- Molecular switch that triggers allergic response in humans identified - Jan 21, 2010
- How reovirus kills cancer cells - Feb 21, 2011
- Scientists find new origin for a critical immune response - Mar 02, 2009
- Scientists figure out why foetus is not rejected - Jun 10, 2012
- Vitamin D protects against viral infections - May 01, 2012
- New drug target for inflammatory bowel disease found - Apr 01, 2011
- Blame your gut for your skin allergies - May 03, 2011
- Way to turn off immune system's allergic reaction discovered - Oct 02, 2010
- Allergic asthmatics more vulnerable during flu season - May 29, 2010
- Drug used to treat asthma 'prevents spread of breast cancer' - Nov 04, 2010
Tags: allergic reaction, allergic reactions, allergic response, allergic responses, allergy drugs, asthma, dendritic cells, deputy editor, diseases, drug target, e john, fighter cells, food allergies, immune cell, immune cells, journal of leukocyte biology, novel drug, researcher, therapeutic opportunities, volunteers